Insider · CIK 0002129698
James Joseph O'Connor
Files at NERV (Minerva Neurosciences, Inc.). First filing -, latest -.
James Joseph O'Connor files SEC Form 4 as officer at NERV (Minerva Neurosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James Joseph O'Connor has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | NERV Minerva Neurosciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +350,800 | $0.00 | $0 | 350,800 | Apr 22, 2026 |
Questions about James Joseph O'Connor
Answered from the filings on this page, as of the latest one.
Is James Joseph O'Connor buying or selling?
James Joseph O'Connor has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James Joseph O'Connor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James Joseph O'Connor has 0.
Where does James Joseph O'Connor file Form 4?
James Joseph O'Connor has filed Form 4 at NERV (Minerva Neurosciences, Inc.) as Chief Business Officer and GC. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.